Trial record 16 of 259 for:    Open Studies | "Edema"

Effect of Normatec Pump for Relief of Leg Edema

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Hillel Yaffe Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01112150
First received: April 12, 2010
Last updated: April 27, 2010
Last verified: April 2010
  Purpose

The investigators hypothesize that leg edema will decrease rapidly when using the NormaTec pump, patients will lose weight, will feel better, will be less prone to infections in their legs and to congestion of the liver. Temporary elevation of intravascular fluid volume by the mobilized edema fluid returned to the intravascular space by pumping may increase cardiac output and renal perfusion and in addition it may distend the right atrium and ventricle thus inducing BNP secretion. Both mechanisms may promote excess fluid removal by the kidneys.


Condition Intervention
Edema
Heart Failure
Pulmonary Hypertension
Device: NormaTec Pump

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Effect of Normatec Pump for Relief of Leg Edema: Short- Intermediate- and Longer-term Outcomes

Resource links provided by NLM:


Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • Weight Loss [ Time Frame: 5 days ] [ Designated as safety issue: No ]
    The weight loss during the pumping pariod is related to fluid loss from edematous legs.


Secondary Outcome Measures:
  • Leg circumference [ Time Frame: 5 Days ] [ Designated as safety issue: No ]
    The leg circumference will be measured before and after each pumping session to determine the effectiveness of the pumping.


Estimated Enrollment: 20
Study Start Date: April 2010
Estimated Study Completion Date: July 2012
Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Pumping group
Patients in this arm will get a pumping session 2-3 times a day .
Device: NormaTec Pump
Normatec Pump
Active Comparator: No pumping
These patients will not receive pumping but only classical treatment clinically indicated (diuretics, oxygen, Digoxin, Nitrates, ACE inhibitors etc, as necessary)
Device: NormaTec Pump
Normatec Pump

  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • hemodynamically stable adult patients with pronounced leg edema from any etiology, on optimal medical therapy (such as diuretics, ACE-I or ARBs, digoxin).
  • documentation of right heart failure by Echo or other modality (CT, MRI, right heart catheterization) and hemodynamic data from Echo is required and an elevated pulmonary artery pressure (> 35 mmHg) is expected in such cases.

Exclusion Criteria:

  • patients in sepsis,
  • hemodynamically unstable,
  • during an acute attack of pulmonary edema,
  • with renal failure (creatinine > 2 mg%),
  • with DVT,
  • psychiatric or noncompliant patients, and
  • patients who will not sign the informed consent form will be excluded from the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01112150

Contacts
Contact: David S. Blondheim, MD 97246304488

Locations
Israel
Hille Yaffe Medical Ceter Recruiting
Hadera, Israel, 38100
Contact: David S Blondheim, MD    97246304488      
Principal Investigator: David S. Blondheim, MD         
Sponsors and Collaborators
Hillel Yaffe Medical Center
  More Information

No publications provided

Responsible Party: David S. Blondheim, Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT01112150     History of Changes
Other Study ID Numbers: 0063-09-HYMC-CTIL
Study First Received: April 12, 2010
Last Updated: April 27, 2010
Health Authority: Israel: Ministry of Health

Keywords provided by Hillel Yaffe Medical Center:
Edema
Heart failure
Pulmonary hypertension
Edema in legs

Additional relevant MeSH terms:
Edema
Heart Failure
Hypertension
Hypertension, Pulmonary
Signs and Symptoms
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on August 19, 2014